申请人:JACOBIO PHARMACEUTICALS CO., LTD
公开号:US20220119386A1
公开(公告)日:2022-04-21
A compound represented by formula I or a pharmaceutically acceptable salt thereof and a use thereof in preparing a drug for treating, stopping or preventing a disease or disorder mediated by FGFR4 activity.